Hysingla ER 40 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FR0MV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,866
Award facts
- Contract value 100% obligated
- $1,865.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,865.60 to AmerisourceBergen Drug Corp for the supply of Hysingla ER 40 mg tablets (60-count units) on January 21, 2026, with an ultimate completion date of January 22, 2026. This is a firm fixed-price, non-set-aside award executed at the vendor's Conshohocken, Pennsylvania location. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.9 billion through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing comprehensive medical product solutions to federal agencies, particularly the Department of Defense and military healthcare systems. The company competes on a full and open basis for federal contract awards and maintains capability across a broad spectrum of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Hysingla ER—a controlled-release opioid pain management medication—reflects the company's ongoing role in supplying critical pharmaceutical commodities to support military and federal medical operations.
Quick answers
Who was awarded contract SPE2DR26FR0MV?
SPE2DR26FR0MV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FR0MV worth?
The government has obligated $1,866 on SPE2DR26FR0MV.
Is contract SPE2DR26FR0MV an order under another contract?
Yes. SPE2DR26FR0MV is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0MV competed?
The extent of competition for SPE2DR26FR0MV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award